Publication:
Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy".

Simple item page
dc.contributor.authorCoto-Hernández, Rubén
dc.contributor.authorFábregas Ruano, María Teresa
dc.date.accessioned2023-02-08T14:46:12Z
dc.date.available2023-02-08T14:46:12Z
dc.date.issued2020-05-06
dc.identifier.doi10.1111/jth.14852
dc.identifier.essn1538-7836
dc.identifier.pmid32302445
dc.identifier.urihttp://hdl.handle.net/10668/15386
dc.issue.number6
dc.journal.titleJournal of thrombosis and haemostasis : JTH
dc.journal.titleabbreviationJ Thromb Haemost
dc.language.isoen
dc.organizationHospital Universitario Puerta del Mar
dc.page.number1519-1520
dc.pubmedtypeLetter
dc.pubmedtypeComment
dc.subject.meshAnticoagulants
dc.subject.meshBetacoronavirus
dc.subject.meshBlood Coagulation Disorders
dc.subject.meshCOVID-19
dc.subject.meshCoronavirus
dc.subject.meshCoronavirus Infections
dc.subject.meshHumans
dc.subject.meshPandemics
dc.subject.meshPneumonia, Viral
dc.subject.meshSARS-CoV-2
dc.titleReply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy".
dc.typeresearch article
dc.volume.number18
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Puerta del Mar

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía